Merz Aesthetics Bolsters U.S. Commercial Team With Strategic Executive Appointments
Merz Aesthetics Expands U.S. Leadership Team With Appointment of Sales and Marketing Veterans to Drive National Growth Strategy Merz Aesthetics, the world’s largest company solely dedicated to the field of…
Grifols Posts €3.68B Revenue and €177M Profit in H1 2025, Advancing Value Creation Plan
Grifols Reports Strong First Half 2025 Results with Robust Revenue Growth, Rising Profitability, and Strategic Progress Across Business Units Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and a world…
Labcorp Secures IVDR CE Mark for PGDx elio™ tissue complete in Europe
Labcorp Earns IVDR CE-Marking for PGDx elio™ tissue complete, Paving the Way for Expanded Personalized Oncology Testing Across Europe In a milestone achievement that advances the accessibility of precision oncology…
Novo Nordisk Names Maziar Mike Doustdar as New President and CEO
Novo Nordisk Ushers in New Era of Leadership as Maziar Mike Doustdar Is Named President and CEO, Effective August 7, 2025 Novo Nordisk, a global healthcare leader renowned for its…
DecisionRx and BeneCard PBF Partner to Personalize Pharmacy Benefits
DecisionRx and BeneCard PBF Unite to Transform Pharmacy Benefits Through Personalized Medication Optimization In a bold move poised to reshape how pharmacy benefits are delivered and experienced across the U.S.,…
AGC Biologics Heidelberg to Supply Drug Substance for Valneva’s Phase II Shigella Vaccine
AGC Biologics’ Heidelberg Facility to Manufacture Drug Substance for Phase II Trials of Valneva’s Four-Valent Shigella Vaccine Candidate AGC Biologics, a global contract development and manufacturing organization (CDMO), announced a…
CHMP Recommends EU Approval of AQNEURSA® for Niemann-Pick Type C
IntraBio’s AQNEURSA® Gains CHMP Recommendation for Niemann-Pick Disease Type C, Signaling Major Breakthrough in Rare Neurological Disorder Treatment In a landmark development for the rare disease community, IntraBio Inc., a…
Avance Clinical Enhances Trial Compliance and Integrity Through ValGenesis Partnership
Avance Clinical Ushers in a New Era of Trial Excellence Through Strategic Digital Validation Partnership with ValGenesis In a strategic move set to redefine the landscape of clinical research quality…
Simulations Plus and Polish Academy Validate AI-Powered ADMET Predictor® Models
Simulations Plus and Polish Academy Scientists Validate AI-Powered Drug Design Models in Breakthrough Discovery Targeting Inflammation and Immune Regulation Simulations Plus, Inc. (Nasdaq: SLP), a prominent developer of modeling and…
Compass Pathways Welcomes Justin Gover to Its Board of Directors
Compass Pathways Appoints Biopharmaceutical Veteran Justin Gover to Board of Directors as Company Advances Toward Potential Regulatory Milestone Compass Pathways plc (Nasdaq: CMPS), a biotechnology company at the forefront of…
Centauri Therapeutics Secures $5.1M from CARB-X for ABX-01 Human Trials
Centauri Therapeutics Secures Additional $5.1M from CARB-X to Propel Lead Antibacterial Candidate ABX-01 Into First-in-Human Trials Centauri Therapeutics Limited, an innovative immunotherapy company leveraging a novel platform for combating infectious…
Bio-Rad Names Rajat Mehta as Executive VP of Global Commercial Operations
Bio-Rad Laboratories Appoints Rajat Mehta as Executive Vice President of Global Commercial Operations, Marking a New Era in Strategic Leadership Herculean succession marks leadership transition following the retirement of Mike…